Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial.
Hara H, Gao C, Kogame N, Ono M, Kawashima H, Wang R, Morel MA, O'Leary N, Sharif F, Möllmann H, Reiber JHC, Sabaté M, Zaman A, Wijns W, Onuma Y, Serruys PW. Hara H, et al. Among authors: sharif f. EuroIntervention. 2020 Dec 18;16(12):e997-e1004. doi: 10.4244/EIJ-D-20-00772. EuroIntervention. 2020. PMID: 32928717 Free article. Clinical Trial.
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience.
Ninomiya K, Serruys PW, Garg S, Hara H, Masuda S, Kageyama S, Kotoku N, Sevestre E, Kumar A, O'Kane P, Zaman A, Farah B, Magro M, Oemrawsingh RM, Möllmann H, Meneveau N, Achenbach S, Lemoine J, Allali A, Gallagher S, Wykrzykowska J, Lesiak M, Silvestri M, Wijns W, Sharif F, Onuma Y. Ninomiya K, et al. Among authors: sharif f. Rev Cardiovasc Med. 2022 Apr 8;23(4):133. doi: 10.31083/j.rcm2304133. eCollection 2022 Apr. Rev Cardiovasc Med. 2022. PMID: 39076220 Free PMC article.
First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G; GSR Investigators. Böhm M, et al. Hypertension. 2015 Apr;65(4):766-74. doi: 10.1161/HYPERTENSIONAHA.114.05010. Epub 2015 Feb 17. Hypertension. 2015. PMID: 25691618 Clinical Trial.
The year in review: coronary interventions.
Gao C, Wang R, Sharif F, Takahashi K, Ono M, Hara H, Tomaniak M, Kawashima H, Modolo R, van Geuns RM, Capodanno D, Byrne RA, Wijns W, Onuma Y, Serruys PW. Gao C, et al. Among authors: sharif f. EuroIntervention. 2020 Apr 17;15(17):1534-1547. doi: 10.4244/EIJ-D-19-01124. EuroIntervention. 2020. PMID: 32091399 Free article. Review. No abstract available.
Computed tomographic angiography in coronary artery disease.
Serruys PW, Kotoku N, Nørgaard BL, Garg S, Nieman K, Dweck MR, Bax JJ, Knuuti J, Narula J, Perera D, Taylor CA, Leipsic JA, Nicol ED, Piazza N, Schultz CJ, Kitagawa K, Bruyne B, Collet C, Tanaka K, Mushtaq S, Belmonte M, Dudek D, Zlahoda-Huzior A, Tu S, Wijns W, Sharif F, Budoff MJ, Mey J, Andreini D, Onuma Y. Serruys PW, et al. Among authors: sharif f. EuroIntervention. 2023 Apr 3;18(16):e1307-e1327. doi: 10.4244/EIJ-D-22-00776. EuroIntervention. 2023. PMID: 37025086 Free PMC article.
Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical update.
Kawashima H, Ono M, Kogame N, Takahashi K, Chang CC, Hara H, Gao C, Wang R, Tomaniak M, Modolo R, Wykrzykowska JJ, De Winter RJ, Sharif F, Serruys PW, Onuma Y. Kawashima H, et al. Among authors: sharif f. Expert Opin Drug Deliv. 2020 Jul;17(7):931-945. doi: 10.1080/17425247.2020.1764932. Epub 2020 May 27. Expert Opin Drug Deliv. 2020. PMID: 32456554 Review.
Quantitative flow ratio for the prediction of coronary events after percutaneous coronary intervention.
Kageyama S, O'Leary N, Chenniganahosahalli Revaiah P, Ninomiya K, Masuda S, Kotoku N, Ilancheran N, Garg S, Harte E, Ni Bheolain G, Reiber JHC, Tu S, Zaman A, Sabaté M, Möllmann H, Sharif F, Lemoine J, Wlodarczak A, Onuma Y, Serruys PW, Multivessel Talent Trial Investigators OBOT. Kageyama S, et al. Among authors: sharif f. EuroIntervention. 2024 Jan 1;20(1):104-106. doi: 10.4244/EIJ-D-23-00561. EuroIntervention. 2024. PMID: 38165111 Free article. No abstract available.
467 results